Georg Beiske Founder of Tribune Therapeutics Backed byNovo HoldingsKasim Kutay SourcesNovo Holdings participates in €23 million Series A for Tribune Therapeutics to advance next-generation anti-fibrotic therapies — 2025-03 Browse all founders · Browse investors
